TipRanks
Go Ultimate75% OFF

Gilla Kaplan Insider Profile

4 Followers

Gilla Kaplan, Director at Avalo Therapeutics, holds 6.33K shares in Avalo Therapeutics (Ticker: AVTX), holds 28.23K shares in Tyra Bioscience (Ticker: TYRA), holds 76.30K shares in Celgene (Ticker: CELG).

Gilla Kaplan's Trading History

AVTX
Avalo Therapeutics
Mar 31, 2026DirectorUninformative Buy43.98K$43.89K
TYRA
Tyra Bioscience
Mar 27, 2026DirectorUninformative Sell87.47K$597.09K
CELG
Celgene
Aug 03, 2017―Informative Sell1.01M$8.26M

You May Also Like

Gilla Kaplan insider profile FAQ

What is the percentage of profitable transactions made by Gilla Kaplan?
The percentage of profitable transactions made by Gilla Kaplan is 70%.
What is the average return per transaction made by Gilla Kaplan?
The average return per transaction made by Gilla Kaplan is -23.30%.
What stocks does Gilla Kaplan hold?
Gilla Kaplan holds: AVTX, CELG, TYRA stocks.
What was Gilla Kaplan’s latest transaction?
Gilla Kaplan’s latest transaction was an Uninformative Buy of $43.98K.
What was Gilla Kaplan's most profitable transaction?
Gilla Kaplan’s most profitable transaction was an Informative Sell of TYRA stock on March 27, 2026. The return on the trade was 41.70%.
What is Gilla Kaplan's role in Avalo Therapeutics?
Gilla Kaplan's role in Avalo Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.